Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5Stage II Prostate Adenocarcinoma 1Prostate Adenocarcinoma 1Breast Neoplasms 1

Interventions

luprolide acetate gel depot 2Leuprolide 2Goserelin 2radium Ra 223 dichloride 1niraparib 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Triptorelin Pamoate 1Receptors, Bombesin 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Observation 1Neoadjuvant Therapy 1Methods 1Magnetic Resonance Spectroscopy 1Gallium 1Educational Status 1Early Intervention, Educational 1Counseling 1Cholecalciferol 1BAY 86-7548 1Adjuvants, Pharmaceutic 168Ga-bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Prostate Adenocarcinoma × BAY 86-7548 × Clear all
NCT02624518 2023-04-10

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Stanford University

Phase 2/3 Completed
122 enrolled 8 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡